electroCore, Inc. (ECOR) shares rallied 11.7% in the last trading session to close at $8.98. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 24.5% gain over the past four weeks.The sudden rise in the stock price can be attributed to the investors’ positive mindset regarding the financial performance of electroCore’s flagship product, gammaCore Sapphire, in the upcoming earnings results. It is a prescription m ...

. ● . electroCore to Participate at LD Micro Main Event VXII October 14, 2024 8:00 AM EDT | Source: LD Micro Rockaway, New Jersey--(Newsfile Corp. - October 14, 2024) - electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the LD Micro Main Event XVII on Tuesday, October 29 at 4:30 p.m. PT at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Dan Goldberger, CEO will be representing the company and will be avail ...

ROCKAWAY, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercialstage bioelectronic medicine and wellness company, today announced that the Air Force Research Laboratories (AFRL) presented new results supporting the ability of electroCore's TAC-STIM (nVNS) to accelerate pilot training. The presentation titled "Accelerating Sensorimotor Learning in A Flight Training Simulation Using Transcutaneous Vagus Nerve Stimulation" was presented on Tuesday, August 26th at the 2024 Medi ...

electroCore, Inc. (NASDAQ:ECOR) Q2 2024 Earnings Conference Call August 7, 2024 4:30 PM ET Company Participants Dan Goldberger - CEO Brian Posner - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Anthony Vendetti - Maxim Group Sean Lee - H.C. Wainwright Tyler Bussian - Brookline Capital Markets Walter Schenker - MAZ Partners Operator Greetings, and welcome to the electroCore Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being reco ...

ROCKAWAY, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercialstage bioelectronic medicine and wellness company, announced today that the Company's CEO, Dan Goldberger, is scheduled to participate in the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference August 12 - 13, 2024. Please contact Needham to schedule a 1x1 meeting. In addition, Brian Posner, CFO of electroCore, Inc. is scheduled to attend the 44th Annual Canaccord Genuity Growth Conference taking plac ...

ElectroCore, Inc. (ECOR) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to loss of $1.03 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 2.56%. A quarter ago, it was expected that this company would post a loss of $0.50 per share when it actually produced a loss of $0.53, delivering a surprise of -6%. Over the last four quarters, the company has surpasse ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share ECOR Nasdaq Capital Market FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ______________ ...

electroCore Announces Second Quarter 2024 Financial Results 1 Seventh consecutive record quarterly net sales of $6.1 million, an increase of 73% over second quarter 2023 Company to host a conference call and webcast today, August 7, 2024 at 4:30 PM EST ROCKAWAY, NJ, August 7, 2024 (GLOBE NEWSWIRE) – electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company and wellness company, today announced second quarter 2024 financial results. Recent Highlights · Seventh consecutive record qua ...

Seventh consecutive record quarterly net sales of $6.1 million, an increase of 73% over second quarter 2023 Company to host a conference call and webcast today, August 7, 2024 at 4:30 PM EST ROCKAWAY, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercialstage bioelectronic medicine company and wellness company, today announced second quarter 2024 financial results. Recent Highlights • Net loss of $2.7 million, a decrease of 46% over second quarter 2023 • Launched our direct- ...

ROCKAWAY, N.J., Aug. 02, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the "Company"), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that on August 1, 2024, Stephen Smith joined electroCore as the Company's VP, Quality, Regulatory, and Compliance, and the Compensation Committee of electroCore's Board of Directors granted 10,000 restricted stock units ("RSUs") to Mr. Smith in connection with the commencement of his employment. The RSUs were granted as an induce ...